PSMC2 is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-Cancer
Wei Huang,1,* Zhengtao Qian,2,* Yuxin Shi,1,3,* Zheming Zhang,3 Rui Hou,1,3 Jie Mei,1,3 Junying Xu,1 Junli Ding1 1Department of Oncology, the Affiliated Wuxi People’s Hospital of Nanjing Medical University, Wuxi, 214023, People’s Republic of China; 2Department of Clinical Lab...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2023-08-01
|
| Series: | Pharmacogenomics and Personalized Medicine |
| Subjects: | |
| Online Access: | https://www.dovepress.com/psmc2-is-a-novel-prognostic-biomarker-and-predicts-immunotherapeutic-r-peer-reviewed-fulltext-article-PGPM |